Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Pfizer’s Breakup Options Shift Even With AstraZeneca Bid
Pfizer’s Breakup Options Shift Even With AstraZeneca Bid
Pfizer’s Breakup Options Shift Even With AstraZeneca Bid
Submitted by
admin
on May 6, 2014 - 9:10am
Source:
Bloomberg
News Tags:
Pfizer
AstraZeneca
restructuring
M&A
Headline:
Pfizer’s Breakup Options Shift Even With AstraZeneca Bid
Do Not Allow Advertisers to Use My Personal information
